Quince Therapeutics, Inc. (QNCX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.14
• Market Cap: $7.35M
• EPS: $-1.20
• 52-Week High: $4.55
• 52-Week Low: $0.13

Market Sentiment

Quince Therapeutics, Inc. currently has a Bearish sentiment score of -0.69.

About Quince Therapeutics, Inc.

Quince Therapeutics, Inc. is a biopharmaceutical innovator headquartered in South San Francisco, California, dedicated to developing precision therapies for rare and debilitating diseases. Leveraging advanced therapeutic platforms and innovative research methodologies, the company addresses critical unmet medical needs to enhance patient quality of life through its targeted treatment portfolio. With a strong and diverse pipeline, Quince Therapeutics is well-positioned for growth and aims to m...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Quince Therapeutics, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does QNCX pay dividends?

Quince Therapeutics, Inc. (QNCX) does not currently pay a regular dividend.

What is QNCX's market cap?

Quince Therapeutics, Inc. (QNCX) has a market capitalization of $7.35M with a current stock price of $0.14.